PIP: Epidemiologic studies suggest that ovarian hormones contribute to the development of
breast cancer at all stages. Early menopause and premenopausal obesity reduces the risk …

PURPOSE: To evaluate the efficacy and safety of first-line, single-agent trastuzumab in
women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS: One …

Purpose To update the American Society of Clinical Oncology (ASCO)/College of American
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …

Purpose To develop a guideline to improve the accuracy of human epidermal growth factor
receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. …

Background Trastuzumab improves survival in the adjuvant treatment of HER-positive
breast cancer, although combined therapy with anthracycline-based regimens has been …

Carcinoma of the breast and ovary account for one-third of all cancers occurring in women
and together are responsible for approximately one-quarter of cancer-related deaths in …

Purpose.— To update key recommendations of the American Society of Clinical Oncology (ASCO)/College
of American Pathologists (CAP) human epidermal growth factor receptor 2 (…

This review examines the direct effects of climate change on insect herbivores. Temperature
is identified as the dominant abiotic factor directly affecting herbivorous insects. There is …

Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor
pathways may cause endocrine resistance in breast cancer. This trial evaluated the effect …

… This cotnpound is active at higher concentrations than strigol (10 '' mol m ' compared to 10
''mol m… by the possibility of an autotrophic solute supply via the parasites own roots (see Press, …